Environmental, Social And Governance Report

Overview

The report presents the Group's 2019-2020 ESG activities under the Hong Kong ESG Reporting Guide, with Board oversight and a stakeholder-based materiality assessment identifying 16 key issues. Environmental data covers emissions, wastewater, solid waste, energy, water and packaging for the two major pharmaceutical subsidiaries. The report also highlights COVID-19 relief, including free Chinese medicine services and a donation of 50,000 surgical masks to Italy.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 April 2019 – 31 March 2020
Publication date: 23 October 2020
Language: English, Chinese
Pages
File size

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services